These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9189830)
1. Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. Cleek RL; Rege AA; Denner LA; Eskin SG; Mikos AG J Biomed Mater Res; 1997 Jun; 35(4):525-30. PubMed ID: 9189830 [TBL] [Abstract][Full Text] [Related]
3. Antisense oligodeoxynucleotide complementary to platelet-derived growth factor A-chain messenger RNA inhibits the arterial proliferation in spontaneously hypertensive rats without altering their blood pressures. Fukuda N; Kubo A; Watanabe Y; Nakayama T; Soma M; Izumi Y; Kanmatsuse K J Hypertens; 1997 Oct; 15(10):1123-36. PubMed ID: 9350586 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of smooth muscle cell proliferation by an antisense oligodeoxynucleotide targeting the messenger RNA encoding proliferating cell nuclear antigen. Speir E; Epstein SE Circulation; 1992 Aug; 86(2):538-47. PubMed ID: 1353419 [TBL] [Abstract][Full Text] [Related]
5. Growth-related responses in arterial smooth muscle cells are arrested by thrombin receptor antisense sequences. Chaikof EL; Caban R; Yan CN; Rao GN; Runge MS J Biol Chem; 1995 Mar; 270(13):7431-6. PubMed ID: 7706289 [TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function. Lu L; Yaszemski MJ; Mikos AG J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S82-91. PubMed ID: 11314800 [TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Graf K; Xi XP; Yang D; Fleck E; Hsueh WA; Law RE Hypertension; 1997 Jan; 29(1 Pt 2):334-9. PubMed ID: 9039124 [TBL] [Abstract][Full Text] [Related]
8. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide. Herbert JM; Guy AF; Lamarche I; Mares AM; Savi P; Dol F J Cell Physiol; 1997 Feb; 170(2):106-14. PubMed ID: 9009139 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Biro S; Fu YM; Yu ZX; Epstein SE Proc Natl Acad Sci U S A; 1993 Jan; 90(2):654-8. PubMed ID: 8421701 [TBL] [Abstract][Full Text] [Related]
10. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro. Lewis KJ; Irwin WJ; Akhtar S J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978 [TBL] [Abstract][Full Text] [Related]
11. [Suppression of the exaggerated growth of vascular smooth muscle cells from SHR by antisense oligodeoxynucleotide to TGF beta]. Fukuda N Nihon Rinsho; 1993 Jun; 51(6):1663-7. PubMed ID: 8320846 [TBL] [Abstract][Full Text] [Related]
12. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Morishita R; Gibbons GH; Ellison KE; Nakajima M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8474-8. PubMed ID: 8104336 [TBL] [Abstract][Full Text] [Related]
13. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. Morishita R; Gibbons GH; Ellison KE; Nakajima M; von der Leyen H; Zhang L; Kaneda Y; Ogihara T; Dzau VJ J Clin Invest; 1994 Apr; 93(4):1458-64. PubMed ID: 8163650 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of smooth muscle cell proliferation and migration in vitro by antisense oligonucleotide to c-myb. Pitsch RJ; Goodman GR; Minion DJ; Madura JA; Fox PL; Graham LM J Vasc Surg; 1996 May; 23(5):783-91. PubMed ID: 8667499 [TBL] [Abstract][Full Text] [Related]
15. Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres. De Rosa G; Maiuri MC; Ungaro F; De Stefano D; Quaglia F; La Rotonda MI; Carnuccio R J Gene Med; 2005 Jun; 7(6):771-81. PubMed ID: 15702489 [TBL] [Abstract][Full Text] [Related]
16. Antisense Ca(2+)-calmodulin dependent protein kinase oligonucleotide inhibits bFGF-induced proliferation of rat vascular smooth muscle cells. Huang SL; Ding B; Li J; Yu QS; Guo ZG Acta Pharmacol Sin; 2000 Mar; 21(3):229-33. PubMed ID: 11324421 [TBL] [Abstract][Full Text] [Related]
17. Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization. Zhang ZD; Xu YQ; Chen F; Luo JF; Liu CD Heart Vessels; 2019 Jan; 34(1):167-176. PubMed ID: 30043157 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of antisense basic fibroblast growth factor oligonucleotides on proliferation of cultured aortic smooth muscle cells induced by angiotensin II in SHR rats. Li GH; Yang GJ Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):132-5. PubMed ID: 10374635 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase C alpha expression is required for heparin inhibition of rat smooth muscle cell proliferation in vitro and in vivo. Herbert JM; Clowes M; Lea HJ; Pascal M; Clowes AW J Biol Chem; 1996 Oct; 271(42):25928-35. PubMed ID: 8824227 [TBL] [Abstract][Full Text] [Related]
20. Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading. Ahmed AR; Bodmeier R Eur J Pharm Biopharm; 2009 Feb; 71(2):264-70. PubMed ID: 18840521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]